BIOLEXIS THERAPEUTICS

Membership Level: Standard Industry

Biolexis Therapeutics is a privately held biopharmaceutical company committed to developing novel targeted therapeutics for cancers, immune-mediated, neurodegenerative, auto-immune, and inflammatory indications.

Biolexis’ empirically developed FIELDS™ technology enables rapid discovery/development of novel clinical candidates. Their modern chemical biology approach, coupled with the real data of machine learning and artificial intelligence, are key to accelerating their discoveries. Their FIELDS platform potentially reduces the timeline and developing costs, while aiming towards the greater probability of success. Biolexis has multiple internally developed agents entering clinical trials in the next 1-2 years.

BioUtah welcomes Biolexis as a new and exciting member!

More